X0202 4 2008-05-15 1 0001027362 SYNPLICITY INC SYNP 0001193053 HAINES ANDREW C/O SYNPLICITY, INC. 600 WEST CALIFORNIA AVE. SUNNYVALE CA 94086 0 1 0 0 Sr VP of Marketing Common Stock 2008-05-15 2008-05-15 4 D 0 3372 D 0 D Common Stock 2008-05-15 2008-05-15 4 D 0 56516 D 0 I By Trust Stock Option (Right to Buy) 5.30 2004-10-04 2004-10-04 4 D 0 75000 0 D 2014-10-04 Common Stock 75000 0 D Stock Option (Right to Buy) 5.48 2006-07-21 2006-07-21 4 D 0 15000 0 D 2016-07-21 Common Stock 15000 0 D Stock Option (Right to Buy) 5.75 2005-07-19 2005-07-19 4 D 0 30500 0 D 2015-07-19 Common Stock 30500 0 D Stock Option (Right to Buy) 5.30 2004-10-04 2004-10-04 4 D 0 75000 0 D 2014-10-04 Common Stock 75000 0 D Stock Option (Right to Buy) 6.52 2007-08-20 2007-08-20 4 D 0 29000 0 D 2017-08-20 Common Stock 29000 0 D Includes 1,000 shares acquired on April 29, 2008 and 372 shares acquired on May 14, 2008 through the issuer's Employee Stock Purchase Plan. Disposed of pursuant to amerger agreement between the issuer, Synopsys, Inc. ("Synopsys") and St. Andrews Acquisition Corp. (the "Merger") in exchange for merger consideration of $8.00 pershare as provided in the merger agreement. This option provided for vesting over 4 years. Upon effectiveness of the Merger and under the terms of the Change of Control Option Acceleration Agreement dated October 4, 2004 between the Reporting Person and the issuer (the "COC Agreement"), this option became fully vested and was exchanged for a fully vested option to purchase 25,438 shares of Synopsys Common Stock with an exercise price of $15.63 per share. This option provided for vesting over 4 years. Upon effectiveness of the Merger and under the terms of the COC Agreement, this option became fully vested and was exchanged for a fully vested option to purchase 5,087 shares of Synopsys Common Stock with an exercise price of $16.16 per share. This option provided for vesting over 4 years. Upon effectiveness of the Merger and under the terms of the COC Agreement, this option became fully vested and was exchanged for a fully vested option to purchase 10,345 shares of Synopsys Common Stock with an exercise price of $16.96 per share. This option provided for vesting over 4 years. Upon effectiveness of the Merger and under the terms of the COC Agreement, this option became fully vested and was exchanged for a fully vested option to purchase 25,438 shares of Synopsys Common Stock with an exercise price of $15.63 per share. This option provided for vesting over 4 years. Upon effectiveness of the Merger and under the terms of the COC Agreement, this option became fully vested and was exchanged for a fully vested option to purchase 9,836 shares of Synopsys Common Stock with an exercise price of $19.23 per share. John J. Hanlon, Atty-in-Fact for Andrew Haines 2008-05-15